US FDA review finds no evidence linking GLP-1 receptor agonists in popular medicines like Wegovy and Zepbound to an increased risk of suicidal thoughts or behaviour ...

The warnings, part of their original approval, were based ​on reports of such events observed with a variety of older ...

Ro entered into a GLP-1 research collaboration with Amgen; The best flu drug Americans aren’t taking; Richard Pazdur urges ...

Learn how to prevent muscle loss while taking GLP-1 medications, with expert tips on protein intake, strength training, and body composition monitoring.

The U.S. health regulator asked drugmakers today to remove warnings about a potential risk of suicidal thoughts from widely ...

There's no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.

Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in active PsA and obesity.

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

Serena Williams opened up about her controversial decision to use GLP-1 medication for weight loss on “The Oprah Podcast.” ...